Business Paid
Asbis bought a 4.5% stake in a biotechnology firm Theramir LTD
11:18
Asbis has acquired a 4.5% stake in Theramir LTD, a biotechnology company developing stem cell and RNA-based technologies for the diagnosis and treatment of cancer, for a total of 800,000 euros.
This article is for subscribers
Warsaw Business Journal subscribers get the full archive (12,248 articles going back to 1995) and the print edition.
SubscribeOr try Poland A.M. free for 7 days, the daily briefing, or see all plans and prices.
